Director, CBER, U.S. Food and Drug Administration
Chief Executive and Scientific Officer, Sanaria Inc.
Chief Research and Development Officer, InDevR
Founder and CEO, Zola Therapeutics; Adjunct Professor, UMass Chan Medical School RNA Therapeutics Institute
CEO and Chief Scientific Officer, Fina Biosolutions
Professor, Disease Intervention and Prevention, Texas Biomedical Research Institute
Professor, Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, Italy
